Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs iShares 0 3 Month Treasury Bond ETF (SGOV) Price & Performance

Nuvation Bio Inc. Class A Common StockTrade
iShares 0 3 Month Treasury Bond ETFTrade

Price performance (Past 24H)

Key statistics

Nuvation Bio Inc. Class A Common Stock vs iShares 0 3 Month Treasury Bond ETF — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.22 (market cap $1.74B), while iShares 0 3 Month Treasury Bond ETF trades at $100.51 (market cap $114.40B). The key difference: iShares 0 3 Month Treasury Bond ETF is far larger — about 65.7× Nuvation Bio Inc. Class A Common Stock's market cap, and iShares 0 3 Month Treasury Bond ETF is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and iShares 0 3 Month Treasury Bond ETF for 50 Days on average.

NUVBSGOV
Market Cap
$1.74B$114.40B
Volume
9,289,61918,879,081
Sector
HealthFixed Income
52-Week High
$9.54$100.72
52-Week Low
$3.41$100.28
Typical Hold Time
0 Days50 Days
Enterprise Value
$1.33B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nuvation Bio Inc. Class A Common Stock

No Aura AI signal available yet.

iShares 0 3 Month Treasury Bond ETF

SGOV (iShares 0-3 Month Treasury Bond ETF) trades at $100.465 with minimal daily movement, reflecting its stable Treasury bill holdings. The ETF shows bearish technical signals with 17 sell indicators versus 4 buy signals, though RSI levels suggest potential oversold conditions. Recent institutional activity includes Envestnet Asset Management reducing its position by 13.2% in Q2 2026. The fund continues its consistent dividend payments with recent distributions of $0.30-$0.31 per share.

SGOV provides exposure to ultra-short-term Treasury securities, offering stability amid bond market volatility. The ETF faces headwinds from rising interest rates but benefits from flight-to-quality flows. Key risks include interest rate sensitivity and potential yield compression if Fed policy shifts dovishly. Current technical weakness may present entry opportunities for income-focused investors seeking capital preservation.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NUVB
100% Buy0% Sell
Avg holding period · 0 Days
SGOV
59% Buy41% Sell
Avg holding period · 50 Days

About Nuvation Bio Inc. Class A Common Stock

Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.

Read more on NUVB →

About iShares 0 3 Month Treasury Bond ETF

SGOV provides exposure to ultra-short-term U.S. Treasury bills with maturities of three months or less. It functions as a high-liquidity cash alternative, seeking to provide current income while maintaining a stable net asset value and minimal interest rate risk.

Read more on SGOV →